Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6314)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 28, 2022 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Warner JB, Guenthner SC, Hardesty JE, McClain CJ, Warner DR, Kirpich IA. Liver-specific drug delivery platforms: Applications for the treatment of alcohol-associated liver disease. World J Gastroenterol 2022; 28(36): 5280-5299 [PMID: 36185629 DOI: 10.3748/wjg.v28.i36.5280] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i36/5280.htm |
| Number | Citing Articles |
| 1 |
Tejinder Pal Singh, Saurabh Kadyan, Harisha Devi, Gwoncheol Park, Ravinder Nagpal. Gut microbiome as a therapeutic target for liver diseases. Life Sciences 2023; 322: 121685 doi: 10.1016/j.lfs.2023.121685
|
| 2 |
Srikar Grandhi, Moawia Al-Tabakha, Prameela Rani Avula, Kuldeep Singh. Enhancement of Liver Targetability through Statistical Optimization and Surface Modification of Biodegradable Nanocapsules Loaded with Lamivudine. Advances in Pharmacological and Pharmaceutical Sciences 2023; 2023: 1 doi: 10.1155/2023/8902963
|
| 3 |
Zi Hong Mok. The effect of particle size on drug bioavailability in various parts of the body. Pharmaceutical Science Advances 2024; 2: 100031 doi: 10.1016/j.pscia.2023.100031
|
| 4 |
Ming-Fo Hsu, Shinichiro Koike, Chang-Shan Chen, Sonia M. Najjar, Tzu-Ching Meng, Fawaz G. Haj. Pharmacological inhibition of the Src homology phosphatase 2 confers partial protection in a mouse model of alcohol-associated liver disease. Biomedicine & Pharmacotherapy 2024; 175: 116590 doi: 10.1016/j.biopha.2024.116590
|